Sodium Chloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09153 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | breast fibrocystic disease | KG + DL |
| 2 | vulvovaginitis | KG + DL |
| 3 | vulvitis | KG + DL |
| 4 | postmenopausal atrophic vaginitis | KG + DL |
| 5 | ulceration of vulva | KG + DL |
| 6 | vulvar neoplasm | KG + DL |
| 7 | blunt duct adenosis of breast | KG + DL |
| 8 | apocrine adenosis of breast | KG + DL |
| 9 | benign mammary dysplasia | KG + DL |
| 10 | fat necrosis of breast | KG + DL |
| 11 | breast abscess | KG + DL |
| 12 | lactation disease | KG + DL |
| 13 | gastroduodenitis | KG + DL |
| 14 | breast adenosis | KG + DL |
| 15 | peptic ulcer disease | KG + DL |
| 16 | strongyloidiasis | KG + DL |
| 17 | amenorrhea (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.